| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.9 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |